Related Experiment Video
Updated: Jan 25, 2026

Adjunctive Diode Laser Therapy and Probiotic Lactobacillus Therapy in the Treatment of Periodontitis and Peri-Implant Disease
Published on: May 9, 2022
Telomere Gene Therapy: Polarizing Therapeutic Goals for Treatment of Various Diseases
JinWoo Hong1, Chae-Ok Yun2,3
1Department of Bioengineering, College of Engineering, Hanyang University, 222 Wangsimni-ro, Seongdong-gu, Seoul 04763, Korea. jhong803@hanyang.ac.kr.
Abstract:
Modulation of telomerase maintenance by gene therapy must meet two polarizing requirements to achieve different therapeutic outcomes: Anti-aging/regenerative applications require upregulation, while anticancer applications necessitate suppression of various genes integral to telomere maintenance (e.g., telomerase, telomerase RNA components, and shelterin complex). Patients suffering from aging-associated illnesses often exhibit telomere attrition, which promotes chromosomal instability and cellular senescence, thus requiring the transfer of telomere maintenance-related genes to improve patient outcomes. However, reactivation and overexpression of telomerase are observed in 85% of cancer patients; this process is integral to cancer immortality. Thus, telomere-associated genes in the scope of cancer gene therapy must be inactivated or inhibited to induce anticancer effects. These contradicting requirements for achieving different therapeutic outcomes mean that any vector-mediated upregulation of telomere-associated genes must be accompanied by rigorous evaluation of potential oncogenesis. Thus, this review aims to discuss how telomere-associated genes are being targeted or utilized in various gene therapy applications and provides some insight into currently available safety hazard assessments.
Insights
Gene therapy targeting telomere maintenance offers dual applications: upregulation for anti-aging and suppression for cancer treatment. Careful evaluation of oncogenesis risk is crucial for vector-mediated gene therapy.
Area of Science:
- Biotechnology
- Genetics
- Oncology
Background:
- Telomere attrition is linked to aging-associated diseases and cellular senescence.
- Telomere maintenance genes are critical for both cellular health and cancer progression.
- Gene therapy offers potential for modulating telomere maintenance.
Purpose of the Study:
- To review the dual role of telomere maintenance genes in gene therapy.
- To discuss gene therapy strategies for anti-aging and anticancer applications.
- To highlight safety assessments for vector-mediated telomere gene therapy.
Main Methods:
- Literature review of gene therapy applications targeting telomere maintenance.
- Analysis of gene therapy requirements for regenerative versus anticancer outcomes.
- Examination of safety hazard assessments for oncogenesis.
Main Results:
- Upregulation of telomere maintenance genes is beneficial for anti-aging/regenerative therapy.
- Suppression of telomere maintenance genes (e.g., telomerase) is necessary for cancer therapy.
- Overexpression of telomerase is a hallmark of many cancers, contributing to immortality.
Conclusions:
- Gene therapy targeting telomere maintenance presents contradictory requirements for different applications.
- Vector-mediated gene transfer necessitates rigorous safety evaluations to mitigate oncogenesis risks.
- Understanding telomere biology is key to advancing gene therapy for aging and cancer.
Related Concept Videos
Gene Therapy
Telomeres and Telomerase
Telomeres and Telomerase
Psychosis: Goals of Pharmacotherapy
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Alzheimer's Disease: Treatment

